Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Blood
|
June 20, 1998
In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype
H Lerat, S Rumin, F Habersetzer, et al.
British Journal of Clinical Pharmacology
|
September 1, 1989
Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients
D Larrey, G Babany, M Tinel, et al.
Journal of Medical Virology
|
June 10, 2003
Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy
E Schvoerer, M C Navas, C Thumann, et al.
Journal of Viral Hepatitis
|
July 11, 1998
Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients
F Zoulim, J Haem, S S Ahmed, et al.
Liver
|
February 13, 2001
A pilot study of recombinant interferon beta-1a for the treatment of chronic hepatitis C
F Habersetzer, N Boyer, P Marcellin, et al.
Gynecologie, Obstetrique & Fertilite
|
February 5, 2011
[Assisted reproductive technique for an opiates dependant couple]
M Weil, Y Yu Tim, M Reichert, et al.
Journal of Internal Medicine
|
April 1, 1994
Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy
F Bissuel, F Bruneel, F Habersetzer, et al.
Hepatology (Baltimore, Md.)
|
August 1, 1989
Genetic predisposition to drug hepatotoxicity: role in hepatitis caused by amineptine, a tricyclic antidepressant
D Larrey, A Berson, F Habersetzer, et al.
Virology
|
September 19, 1998
Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties
F Habersetzer, A Fournillier, J Dubuisson, et al.
Gastroenterologie Clinique Et Biologique
|
May 10, 2008
[Neutralizing antibodies in hepatitis C virus infection]
S Fafi-Kremer, M B Zeisel, E Schvoerer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Blood
|
June 20, 1998
In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype
H Lerat, S Rumin, F Habersetzer, et al.
British Journal of Clinical Pharmacology
|
September 1, 1989
Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients
D Larrey, G Babany, M Tinel, et al.
Journal of Medical Virology
|
June 10, 2003
Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy
E Schvoerer, M C Navas, C Thumann, et al.
Journal of Viral Hepatitis
|
July 11, 1998
Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients
F Zoulim, J Haem, S S Ahmed, et al.
Liver
|
February 13, 2001
A pilot study of recombinant interferon beta-1a for the treatment of chronic hepatitis C
F Habersetzer, N Boyer, P Marcellin, et al.
Gynecologie, Obstetrique & Fertilite
|
February 5, 2011
[Assisted reproductive technique for an opiates dependant couple]
M Weil, Y Yu Tim, M Reichert, et al.
Journal of Internal Medicine
|
April 1, 1994
Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy
F Bissuel, F Bruneel, F Habersetzer, et al.
Hepatology (Baltimore, Md.)
|
August 1, 1989
Genetic predisposition to drug hepatotoxicity: role in hepatitis caused by amineptine, a tricyclic antidepressant
D Larrey, A Berson, F Habersetzer, et al.
Virology
|
September 19, 1998
Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties
F Habersetzer, A Fournillier, J Dubuisson, et al.
Gastroenterologie Clinique Et Biologique
|
May 10, 2008
[Neutralizing antibodies in hepatitis C virus infection]
S Fafi-Kremer, M B Zeisel, E Schvoerer, et al.
Page
of 3